Comprehensive cardiovascular disease risk reduction in a cardiac rehabilitation setting

American Journal of Cardiology

Volumn 80, Issue 8 B, 1997, Pages

  Gordon, Neil F ^a   Haskell, William L ^b  

^a Candler Hospital   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; EXERCISE; FOLLOW UP; HEART REHABILITATION; HUMAN; HUMAN CELL; LIFESTYLE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; TRAINING; TREATMENT PLANNING;

EID: 0030732256     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00825-4     Document Type: Conference Paper

References (11)

1. Pearson TA, Fuster V. 27th Bethesda Conference. Executive summary. J Am Coll Cardiol. 27:1996;961-963.
2. Smith SC. AHA President's letter. Circulation. 92:1995;1.
3. Balady GJ, Fletcher BJ, Froelicher ES, Hartley LH, Krauss RM, Oberman A, Pollock ML, Taylor CB. AHA position statement. Cardiac rehabilitation programs. A statement for healthcare professionals from the American Heart Association. Circulation. 90:1994;1602-1610.
4. Bairey Merz CN Rozanski A. Remodeling cardiac rehabilitation into secondary prevention programs. Am Heart J. 132:1996;418-427.
5. Wenger NK, Froelicher ES, Smith LK, Ades PA, Berra K, Blumenthal JA, Certo CME, Dattilo AM, Davis D, DeBusk RF, Drozda JP, Fletcher BJ, Franklin BA, Gaston H, Greenland P, McBride PE, McGregor CGA, Oldridge NB, Piscatella JC, Rogers FJ. Cardiac rehabilitation. 1995;U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute. AHCPR Publication No. 96-0672. October, Clinical Practice Guidelines No 17. Rockville, MD.
6. Smith SC, Blair SN, Criqui MH, Fletcher GF, Fuster V, Gersh BJ, Gotto AM, Gould KL, Greenland P, Grundy SM, Hill MN, Hlatky MA, Houston-Miller N, Krauss RM, LaRosa J, Ockene IS, Oparil S, Pearson TA, Rapaport E, Starke RD. AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. Circulation. 92:1995;2-4.
7. Swan HJC, Gerch BJ, Graboys TB, Ullyot DJ. Task Force 7 Evaluation and management of risk factors for the individual patient (case management) . J Am Coll Cardiol. 27:1996;1030-1039.
8. Superko HR, Krauss RM. Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management. Circulation. 90:1994;1056-1069.
9. Haskell WL, Alderman EL, Fair JM, Maron DJ, Mackey SF, Superko HR, Williams PT, Johnstone IM, Champagne MA, Krauss RM, Farquhar JW. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 89:1994;975-990.
10. Quinn TG, Alderman EL, McMillan A, Haskell W. Development of new coronary atherosclerotic lesions during a 4-year multifactor risk reduction program The Stanford Coronary Risk Intervention Project (SCRIP) . J Am Coll Cardiol. 24:1994;900-908.
11. Pearson TA, McBride PE, Houston Miller N, Smith SC. Task Force 8 Organization of preventive cardiology services . J Am Coll Cardiol. 27:1996;1039-1047.